about
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform ba...
Read More
2.70
0.14
(5.47%)
682.2K
XNAS Volume
XNAS 11 Sep, 2025 12:57 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Editas Medicine Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..